ASCO: Experimental vaccine made from frozen immune cells shows promise for prostate cancer patients
Thursday, June 2, 2011 - 15:00
in Health & Medicine
Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data being presented by researchers from the Kimmel Cancer Center at Jefferson at the 2011 American Society of Clinical Oncology annual meeting in Chicago on Saturday, June 4.